Related Experiment Videos
Advances in treatment of chronic hepatitis C: 'pegylated' interferons
Khavir A Sharieff1, David Duncan, Zobair Younossi
1Inova Transplant Center at Inova Fairfax Hospital, Falls Church, Virginia 22042, USA.
Cleveland Clinic Journal of Medicine
|May 7, 2002
Abstract:
New regimens consisting of pegylated interferons plus ribavirin may produce a sustained virologic response in more than 50% of cases of chronic hepatitis C. In contrast, the combination of standard interferon alfa and ribavirin, which was the standard of care until recently, produced a sustained virologic response in 35% to 40% of cases. As the efficacy of newer regimens improves, additional steps to adequately manage their side effects and maximize adherence may become crucial.